Welcome to EpilepsyU.com a social network dedicated to the epilepsy community

Author: EpilepsyU

Researchers discover novel mode of neurotransmitter-based communication

Researchers at the University of California, Irvine School of Medicine have discovered the first example of a novel mode of neurotransmitter-based communication. The discovery, published in Nature Communications, challenges current dogma about mechanisms of signaling in the brain, and uncovers new pathways for developing therapies for disorders like epilepsy, anxiety and chronic pain.

Call to action builds on 2015 WHO Resolution on Epilepsy, which aims to improve knowledge, services, and treatment of epilepsy worldwide

Representatives from the International League against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE), alongside prominent members of the Global epilepsy community, are meeting this week to encourage World Health Assembly (WHA) members and the World Health Organization (WHO) to continue to recognize epilepsy as a global health priority in countries around the world.   Coincidi...

Mechanism underlying malformation associated with severe epilepsy is revealed

Study suggests dysregulation of gene NEUROG2 could be linked to development of focal cortical dysplasia, one of the most common causes of drug-resistant epilepsy   One of the most frequent causes of drug-resistant epilepsy, considered a difficult disease to control, is a brain malformation known as focal cortical dysplasia.   Patients with this problem present with discreet disorganizati...

With Epilepsy on The Rise, Thousands of Americans Are Turning To The Internet For Advice

Epilepsy is on the rise in the USA, recent figures released by the Centers for Disease Control and Prevention (CDC) confirm. According to a 2018 report issued by the CDC, “Active Epilepsy and Seizure Control in Adults — United States, 2013 and 2015”, the number of Americans self-reporting epilepsy rose from 2.3 million in 2010, to approximately 3 million in 2015. A 1994 report — Current Trends Pre...

Cannabis Compound Confirmed as Epilepsy Treatment for Atonic Seizures (Drop Attacks)

Cannabidiol (CBD), a compound derived from the cannabis plant that does not produce a “high” and has been an increasing focus of medical research, was shown in a new large-scale, randomized, controlled trial to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox–Gastaut syndrome.   In the new study comparing 2 doses of CBD to a placeb...

Epilepsy, Medical Marijuana and CBD: Myths and Facts

While a Food and Drug Administration advisory panel recently recommended pharmaceutical-grade cannabidiol (CBD) as a treatment for two rare forms of epilepsy, CBD medication is not the same thing as medical marijuana, which is more available than ever before and promoted for wide variety of health conditions. The American Epilepsy Society (AES) wants to alert the 3 million people with epilepsy abo...

Child Protective Services called on parents treating kid with CBD oil for epilepsy

Photo: Jaelah Jerger (L) and Vala Jerger (R) (Photo courtesy their mother.)   Indiana allows CBD oil for epilepsy, but the girl’s particular form of epilepsy is not protected.   It all began last August. Even though the laws in Indiana for cannabis are strict, the Jergers knew there were certain laws permitting CBD oil use for epilepsy patients. Concerned about the side-effects of antiep...

Many States Considering Illegal CBD Crackdown Laws

Michigan, Texas and many other states are looking at doing what the Texas Department of State Health is thinking about; a crackdown on foods and oils which contain CBD.   CBD is a component in marijuana/hemp plants. Unlike THC, the psychedelic active ingredient in cannabis, it cannot actually get you high; it’s frequently utilized to deal with seizure disorders.   Texas and other states ...

UCB Announces BRIVIACT® (Brivaracetam) now Approved by FDA to Treat Partial-onset (Focal) Seizures in Pediatric Epilepsy Patients

BRIVIACT® (brivaracetam) CV oral formulations are approved as a monotherapy or adjunctive therapy in patients four years of age and older with partial-onset seizures   – Approval provides pediatric epilepsy patients a treatment option which can be initiated at a therapeutic dose from day one   – Pediatric epilepsy is the most common, serious neurological disorder among childr...

Phelan-McDermid Syndrome Treatment Commences Clinical Trial Recruitment

This week, AMO Pharma Limited announced the commencement of patient recruitment for an interventional study of AMO-01, an investigational Ras-ERK pathway inhibitor for the treatment of Phelan-McDermid syndrome (PMS).   “Treatment of Phelan-McDermid syndrome represents a significant area of unmet need in healthcare, and AMO Pharma is grateful to the research team at Mt. Sinai as well as ...

FDA Reports a Life-Threatening Immune Reaction to Lamotrigine: What You Should Know

A rare but life-threatening immune reaction in response to lamotrigine (Lamictal) requires prompt diagnosis and treatment, according to a recent alert from the U.S. Food and Drug Administration (FDA).   On April 25, the FDA issued what it calls a “drug safety communication” about the risk of a condition so rare that few neurologists have heard of it: hemophagocytic lymphohistiocyt...

Red Sea fungus yields leads for new epilepsy drugs

New treatments for epilepsy are sorely needed because current medications don’t work for many people with the disease. To find new leads, researchers have now turned to the sea — a source of unique natural products that have been largely untapped for prospective drugs. The scientists report in the journal ACS Chemical Neuroscience that two metabolites produced by a fungus from the Red ...

Lost Password

Register